Multiple System Atrophy (MSA): Clinical Trials

2 trials for Multiple System Atrophy (MSA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Recruiting 2

Follow Multiple System Atrophy (MSA): new trials by email Literature Review of Multiple System Atrophy (MSA) trials Research Report on Multiple System Atrophy (MSA)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
[¹⁸F]MODAG-009 PET imaging - Multiple System Atrophy (MSA), Healthy Adult
Early Phase 1RecruitingMODAG GmbH132026-05-132026-06-10
[18F]ACI-15916 PET in α-synucleinopathies
[18F]ACI-15916 - Parkinson's Disease (PD), Multiple System Atrophy (MSA)
Early Phase 1RecruitingAC Immune SA462025-03-202026-10-28

Narrower conditions

Multiple System Atrophy (2)  ·  Parkinson Disease (2)  ·  Lewy Body Disease (1)

Broader conditions

Autonomic Nervous System Diseases (2)  ·  Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Movement Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Parkinsonian Disorders (2)  ·  Primary Dysautonomias (2)  ·  Synucleinopathies (2)  ·  Dementia (1)  ·  Mental Disorders (1)  ·  Neurocognitive Disorders (1)

Sponsors

AC Immune SA (1)  ·  MODAG GmbH (1)

Countries

Sweden (1)  ·  United States (1)

Top investigators

Andrea Varrone, Prof. (1)